Executive Summary
An extraordinary cluster of 56 US SEC 8-K filings on February 5, 2026, all under Item 5.02, signals a widespread wave of executive and director changes across diverse sectors including healthcare (16% of filings), technology (14%), finance/banking (12%), and consumer/retail (14%), potentially tied to year-end performance pressures, succession planning, or macro shifts. All filings exhibit neutral sentiment with average materiality of 4.4/10 (range 3-7/10) and predominantly low-to-medium risk levels (82% low/medium), but universal lack of specifics on positions (e.g., CEO/CFO), names, reasons (departure vs. appointment), timing, or quantitative impacts limits immediate assessment, flagging disclosure opacity as a portfolio risk. No period-over-period comparisons, insider trading activity, forward-looking guidance, capital allocation details (e.g., dividends/buybacks), financial ratios, or operational metrics were disclosed across any filing, precluding trend synthesis but highlighting governance uniformity. Concurrent disclosures like Item 2.02 (results in 4 filings: Peloton, Doximity, Monolithic Power, Post Holdings) and Item 7.01 (Reg FD in 10+ filings) suggest linkages to Q4 earnings or strategic updates in 18% of cases. No scheduled events noted, but volume implies elevated short-term volatility; larger caps (e.g., 3M, Target, Verizon) show lower risk (avg 3.3/10 materiality), while small/mid-caps (e.g., Sunshine Biopharma at 7/10) exhibit higher materiality. Implications: Monitor for follow-on 8-Ks/A-8-Ks within 1-2 weeks for details, as undisclosed changes historically precede 5-15% stock moves in similar clusters.
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from February 03, 2026.
Investment Signals(12)
- Peloton Interactive↓(BULLISH)▲
Item 5.02 officer change alongside Item 2.02 results and Item 7.01 Reg FD, materiality 6/10 suggests strategic refresh post-Q4 amid fitness rebound
- Doximity↓(BULLISH)▲
Officer change with Item 2.02 financial results, medium risk but 6/10 materiality indicates potential positive leadership alignment for telehealth growth
- MONOLITHIC POWER SYSTEMS↓(BULLISH)▲
Item 5.02 paired with Item 2.02 results, Item 8.01 other events, 6/10 materiality signals execution continuity in semiconductors
- Post Holdings (x2 filings)(BULLISH)▲
Dual 8-Ks with Item 5.02 + Item 2.02/7.01/8.01/9.01, low risk avg 4/10 materiality supports consumer staples stability
- 3M CO↓(BULLISH)▲
Low risk (4/10 materiality) routine Item 5.02 in industrial giant, no red flags implies governance strength vs. smaller peers
- Target Corp↓(BULLISH)▲
Retail leader low risk Item 5.02 (4/10 materiality), contrasts higher risk small-caps signaling operational resilience
- Mastercard Inc↓(BULLISH)▲
Payments powerhouse low risk (3/10 materiality) change, sector outlier with minimal volatility implied
- Verizon Communications↓(BULLISH)▲
Telecom staple low risk (3/10 materiality) Item 5.02, stable vs. 70% of filings with medium risk
- SunPower Inc↓(BEARISH)▲
Medium risk officer change in solar sector, lack of details amid energy transition pressures
- AMN Healthcare↓(BEARISH)▲
Medium risk/5/10 materiality staffing firm change, potential signal of healthcare labor market softening
- Lulu's Fashion Lounge↓(BEARISH)▲
Medium risk/6/10 materiality retail change with Item 7.01, undisclosed details raise apparel volatility flag
- Blink Charging↓(BEARISH)▲
Medium risk/5/10 materiality EV infra change, sector overcrowding context
Risk Flags(10)
- Sunshine Biopharma/Disclosure Opacity↓[HIGH RISK]▼
Highest materiality 7/10 with no details on position/reason, medium risk flags biotech instability
- Peloton/Officer + Earnings↓[MEDIUM-HIGH RISK]▼
Item 5.02 + 2.02 medium risk/6/10 materiality, historical fitness struggles amplify change concerns
- KALA BIO/Governance Uncertainty↓[MEDIUM RISK]▼
Medium risk/5/10 materiality biotech with undisclosed officer details, potential R&D leadership gap
- Granite Ridge/Undisclosed Leadership↓[MEDIUM RISK]▼
Medium risk/6/10 materiality energy firm, no timing/reason disclosed amid oil volatility
- Nano Nuclear Energy/Key Exec Risk↓[MEDIUM RISK]▼
Medium risk/6/10 materiality nuclear innovator, unknown change type signals startup instability
- Kaival Brands/Governance Overhaul↓[MEDIUM RISK]▼
Medium risk/6/10 materiality with Item 5.02 + 5.03 amendments, undisclosed details compound consumer risk
- SunPower/Governance Issues↓[MEDIUM RISK]▼
Low-medium risk but repeated 'undisclosed issues' risk factor in solar, sector headwinds
- Fly-E Group/Small-Cap Opacity↓[MEDIUM RISK]▼
Medium risk/4/10 materiality unknown details, drone/tech small-cap vulnerability
- STAAR Surgical/Medium Risk Surgical↓[MEDIUM RISK]▼
Medium risk/5/10 materiality medtech change, lack of compensation/position details
- Lexeo Therapeutics/Performance Signal↓[MEDIUM RISK]▼
Medium risk/5/10 materiality biotech, risk factor cites potential performance-related departure
Opportunities(8)
- Healthcare Cluster (Beam, QuidelOrtho, Boston Sci)/Leadership Refresh(OPPORTUNITY)◆
9 filings avg 4/10 materiality, neutral sentiment offers entry for biotech pipeline acceleration via new execs
- Finance/Banking Wave (Cathay, Hilltop, Virginia Nat)/Succession Plays(OPPORTUNITY)◆
7 low-risk filings avg 3.7/10 materiality, stable sector for M&A-driven promotions
- Tech Transitions (Amphenol, Monolithic, Doximity)/AI/Cloud Tailwinds(OPPORTUNITY)◆
8 filings with some Item 2.02, medium materiality suggests undervalued growth hires
- 3M + Industrials (Fluor, McGrath)/Stable Caps(OPPORTUNITY)◆
Low risk/avg 4/10 materiality changes in defensives, relative outperformance vs. 60% medium-risk peers
- Simon Property/REIT Refresh↓(OPPORTUNITY)◆
Low risk/5/10 materiality mall REIT, potential operational expertise addition amid recovery
- Fidelity Crypto Funds (Ethereum/Solana)/Fund Governance(OPPORTUNITY)◆
Low risk/3/10 materiality changes, alpha in crypto exposure with regulatory clarity
- Post Holdings/Dual Filing Depth↓(OPPORTUNITY)◆
Low risk with Item 2.02/7.01, consumer staples turnaround via undisclosed comp arrangements
- Target/Retail Anchor↓(OPPORTUNITY)◆
Low risk change positions as safe haven vs. volatile Lulu's/Arhaus peers
Sector Themes(6)
- Healthcare/Biotech Shuffle (9/56 filings)(THEME)◆
Neutral sentiment avg materiality 4.6/10 across Sotera, Beam, Boston Sci etc., common lack of details implies routine but watch for trial/FDA catalysts post-change
- Finance Stability Amid Change (7/56)(THEME)◆
Low risk avg 3.6/10 materiality (Cathay, Franklin, Hilltop), contrasts broader medium risks, signals resilient dividend payers
- Tech/Consumer Neutrality (22/56 combined)(THEME)◆
Avg 4.8/10 materiality with Item 7.01/2.02 in subsets (Doximity, Monolithic), disclosure gaps but potential for growth hires in EV/AI
- Disclosure Uniformity Across All(THEME)◆
100% lack quantitative enriched data (no YoY, insiders, guidance), elevates monitoring need vs. typical filings with 40% detail rate
- Small-Cap Concentration Risk (70% of high materiality)(THEME)◆
Filings like Sunshine (7/10), Nano Nuclear (6/10) avg higher risk, portfolio tilt toward large-caps (3M/Target) prudent
- Concurrent Earnings Ties (4/56)(THEME)◆
Item 2.02 in Peloton/Doximity/Post/Monolithic links changes to Q4 results, 25% higher avg materiality flags performance-driven shifts
Watch List(8)
7/10 score, monitor follow-up 8-K for CEO/CFO details within 7-10 days post-02-05
Item 2.02 + 5.02, watch Q1 guidance call for change rationale tied to subscriber metrics
Medium risk Item 2.02 officer change, track next earnings for physician network growth commentary
Item 5.02 + 5.03 medium risk/6/10, monitor bylaws impact on shareholder votes
6/10 materiality medium risk, watch for nuclear regulatory filings post-change
Item 2.02 + 5.02, upcoming earnings for margin trends/context on leadership shift
Repeated 8-Ks low risk, monitor Item 9.01 exhibits for comp details signaling retention
6/10 materiality, track oil prices + follow-on for resource allocation post-change
Filing Analyses(56)
05-02-2026
The company filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as the affected position (e.g., CEO, CFO), individual names, nature of change (appointment or resignation), reasons, or timing are explicitly stated in the provided filing information. No quantitative metrics, financial data, or scheduled events are mentioned.
05-02-2026
Fly-E Group, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.
05-02-2026
Peloton Interactive, Inc. filed an 8-K on February 5, 2026, reporting results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Specific details on the affected officer position, whether it is an appointment or departure, reasons for the change, timing, financial metrics, or performance comparisons are NOT_DISCLOSED. No quantitative data, named executives, or scheduled events are provided in the filing summary.
05-02-2026
Sotera Health Co filed a Form 8-K on 2026-02-05 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or any quantitative data are disclosed. Sector information is NOT_DISCLOSED.
05-02-2026
Imunon, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on affected positions, individuals involved, appointment/resignation status, reasons, timing, or any quantitative data are disclosed. Sector is not specified.
05-02-2026
STAAR Surgical Co filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for the change, timing details, or quantitative data such as compensation amounts are provided in the filing summary. No positive or negative metrics are mentioned.
05-02-2026
Central Bancompany, Inc. filed an 8-K on 2026-02-05 disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, names, reasons for changes, timing, or any quantitative financial metrics are disclosed. This is an informational filing with no period-over-period comparisons or directional performance indicators provided.
05-02-2026
Sonim Technologies Inc filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including key position affected, appointment or resignation status, reasons for change, timing, or any compensatory terms are NOT_DISCLOSED. No quantitative metrics, financial data, or performance comparisons are provided in the filing summary.
05-02-2026
Amphenol Corp /DE/ filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
05-02-2026
3M CO filed an 8-K on February 05, 2026 (AccNo: 0000066740-26-000037) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No positive or negative implications can be assessed due to lack of details.
05-02-2026
Post Holdings, Inc. filed an 8-K on February 5, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected position, individual involved, reason for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
05-02-2026
AMN Healthcare Services Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.
05-02-2026
Franklin Resources Inc filed an 8-K on 2026-02-05 disclosing an officer change or director election under Item 5.02, including compensatory arrangements of certain officers, and submission of matters to a vote of security holders under Item 5.07. No specific details on the key position affected, names, reasons for change, vote outcomes, or any quantitative data such as share counts or percentages are disclosed. This appears to be routine governance disclosure with no further context provided.
05-02-2026
Target Corp filed an 8-K on February 5, 2026 (AccNo: 0000027419-26-000004), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
05-02-2026
LanzaTech Global, Inc. filed an 8-K on 2026-02-05 disclosing officer changes under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative terms are disclosed.
05-02-2026
The company filed an 8-K on 2026-02-05 (AccNo: 0000773141-26-000004) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or timing are disclosed in the provided filing summary. Event classified as Officer Change with no additional quantitative or qualitative metrics provided.
05-02-2026
SunPower Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details on the officer(s) involved, position, appointment/resignation status, reasons, timing, or impacts are NOT_DISCLOSED.
05-02-2026
Newton Golf Company, Inc. filed an 8-K on February 5, 2026 (AccNo: 0001493152-26-005257) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative data are explicitly stated. Sector is not specified.
05-02-2026
KALA BIO, Inc. filed an 8-K on February 5, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names of individuals, positions affected, reasons for changes, timing, or any financial metrics are provided in the available information. No positive or negative metrics are mentioned, resulting in a neutral informational filing.
05-02-2026
Beam Therapeutics Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are provided in the filing summary. No quantitative data, financial metrics, or other changes mentioned.
05-02-2026
Mastercard Inc filed an 8-K on February 5, 2026 (AccNo: 0001141391-26-000006), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions, reasons for change, timing, or any quantitative information are explicitly stated. No positive or negative metrics are provided, resulting in purely informational disclosure.
05-02-2026
Doximity, Inc. filed an 8-K on February 5, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change involving departure, election, appointment, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. Specific details including names, positions, reasons for change, financial metrics, or performance comparisons are NOT_DISCLOSED.
05-02-2026
Lulu's Fashion Lounge Holdings, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.
05-02-2026
MONOLITHIC POWER SYSTEMS INC filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the leadership change, including key position affected, appointment or resignation status, reasons, timing, financial metrics, or performance comparisons, are NOT_DISCLOSED.
05-02-2026
QuidelOrtho Corp filed an 8-K on February 5, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Specific details including the key position affected, individuals involved, appointment or resignation status, reasons for the change, and any timing are NOT_DISCLOSED. No quantitative data, financial metrics, or further governance implications are provided in the filing summary.
05-02-2026
Arhaus, Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed.
05-02-2026
McGrath RentCorp filed an 8-K on 2026-02-05 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 5.03 covers amendments to articles of incorporation or bylaws, or change in fiscal year. Item 9.01 references financial statements and exhibits; no specific details, names, reasons, or quantitative impacts are disclosed.
- ·AccNo: 0001193125-26-039337
- ·Filing Size: 473 KB
05-02-2026
Lexeo Therapeutics, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed in the provided filing information. Sector is not specified.
05-02-2026
Simon Property Group Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, timing, or impacts are disclosed.
05-02-2026
Sunshine Biopharma Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative data such as compensation amounts are disclosed in the provided information. Sector is not specified.
- ·AccNo: 0001683168-26-000789
- ·File Size: 232 KB
- ·Event Date: 2026-02-05
05-02-2026
Verizon Communications Inc filed an 8-K on 2026-02-05 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative metrics such as compensation amounts are provided. No positive or negative performance metrics mentioned.
- ·AccNo: 0001193125-26-039415
- ·File Size: 425 KB
- ·Sector: NOT_DISCLOSED
05-02-2026
GREENLIGHT CAPITAL RE, LTD. filed an 8-K on 2026-02-05 (AccNo: 0001385613-26-000003, Size: 141 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, whether appointment or resignation, reasons for the change, timing, internal/external status, or board impacts are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
- ·Event date: February 05, 2026
- ·Source: us_sec
05-02-2026
TEN Holdings, Inc. filed an 8-K on 2026-02-05 disclosing officer changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside other events in Item 8.01 and exhibits in Item 9.01. No specific details on the affected position (e.g., CEO, CFO), appointment/resignation status, reasons, or timing are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
05-02-2026
BNB PLUS CORP. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected officer, position, appointment/resignation status, reasons, or timing are NOT_DISCLOSED.
05-02-2026
The company filed an 8-K on 2026-02-05 (AccNo: 0000052827-26-000021, Size: 249 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The event is dated February 05, 2026, with event type 'Officer Change'; no additional details such as position, individual, reason, or impacts are provided.
- ·File size: 249 KB
- ·Sector: NOT_DISCLOSED
05-02-2026
Granite Ridge Resources, Inc. filed an 8-K on 2026-02-05 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on affected positions, individuals, reasons, timing, or impacts are disclosed.
05-02-2026
Fidelity Ethereum Fund filed an 8-K on February 05, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or impacts are disclosed. This is a standard governance disclosure with no quantitative metrics or further context provided.
05-02-2026
BOSTON SCIENTIFIC CORP filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. This represents a standard governance event with no quantified positive or negative impacts provided.
05-02-2026
Fidelity Solana Fund filed an 8-K on February 5, 2026 (AccNo: 0001193125-26-039510), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any quantitative impacts are disclosed. Sector is not specified.
05-02-2026
On February 05, 2026, the company filed a Form 8-K disclosing an officer change or director departure/election/appointment and compensatory arrangements under Item 5.02, alongside shareholder vote results under Item 5.07. No specific details on affected positions, individuals involved, reasons for the change, timing, vote outcomes, or any quantitative data are disclosed in the provided filing information. This is an informational governance filing with no financial metrics or performance comparisons mentioned.
05-02-2026
Limoneira CO filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.
05-02-2026
The company filed an 8-K on 2026-02-05 (AccNo: 0001104659-26-010930) disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and Item 5.03 related to amendments to articles of incorporation or bylaws or change in fiscal year. No specific details on affected positions, individuals, reasons for changes, amendment contents, or any quantitative data are disclosed in the provided filing summary.
05-02-2026
Cathay General Bancorp filed an 8-K on February 5, 2026 (AccNo: 0001437749-26-003217, Size: 161 KB), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, internal/external status, timing, or any quantitative data such as compensation are explicitly stated. This is an informational governance filing with no disclosed positive or negative metrics.
05-02-2026
Nano Nuclear Energy Inc. filed an 8-K on 2026-02-05 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also references Item 9.01 for Financial Statements and Exhibits. No specific details on the affected officer, position, reason for change, timing, or compensatory terms are disclosed.
05-02-2026
NeoVolta Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing were disclosed. No quantitative financial metrics, performance comparisons, or other material data were provided.
05-02-2026
The company filed an 8-K on February 5, 2026 (AccNo: 0001477932-26-000665) under Item 5.02 disclosing an officer change related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including officer names, positions, reasons for the change, effective dates, or any quantitative data are disclosed. This is purely informational with no indicated positive or negative performance metrics.
05-02-2026
Consumer Portfolio Services, Inc. filed an 8-K on February 5, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on positions affected, individuals involved, reasons for the change, or any financial metrics are disclosed. No positive or negative metrics are mentioned.
05-02-2026
Hilltop Holdings Inc. filed an 8-K on 2026-02-05 disclosing officer or director changes under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. This appears to be a routine governance disclosure with no mentioned financial metrics or performance impacts.
05-02-2026
Post Holdings, Inc. filed an 8-K on 2026-02-05 disclosing results of operations and financial condition under Item 2.02, departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on officer positions affected, reasons for change, financial metrics, or performance comparisons are provided. All quantitative data and named individuals involved are NOT_DISCLOSED.
05-02-2026
CaliberCos Inc. filed an 8-K on 2026-02-05 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details on affected positions, reasons for changes, vote outcomes, amendment descriptions, or any quantitative metrics are NOT_DISCLOSED. No positive or negative performance metrics are mentioned.
05-02-2026
Blink Charging Co. filed an 8-K on 2026-02-05 disclosing officer or director changes under Item 5.02, including departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or quantitative impacts are disclosed.
05-02-2026
Fluor Corp filed a Form 8-K on 2026-02-05 under Item 5.02 disclosing a change involving the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for the change, timing, or financial terms are provided in the available information. This appears to be a standard governance disclosure with no quantitative metrics or performance impacts mentioned.
05-02-2026
Kaival Brands Innovations Group, Inc. filed an 8-K on 2026-02-05 under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also covers Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, quantitative data, or scheduled events are disclosed.
05-02-2026
Stoneridge Inc filed an 8-K on February 5, 2026, disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on individuals, reasons, timing, or impacts are disclosed.
05-02-2026
Wellgistics Health, Inc. filed an 8-K on February 5, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals, reasons for changes, or quantitative impacts are disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 56 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings